Karah Herdman Parschauer, EVP and Chief Legal Officer at Ultragenyx Pharmaceutical, sold RARE on Jun 15, 2026
Data as of Oct 16
▼ SELL$46.8K1,899 shares at $24.62Karah Herdman Parschauer EVP and Chief Legal OfficerRARE Ultragenyx Pharmaceutical Inc.
- Traded
- Jun 15, 2026
- Disclosed
- Jun 15, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RARE since disclosure
−42.7%
after the sale
Similar stocks (XLV) since disclosure
+15.6%
XLV — its sector index fund
Change in closing price from Jun 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.